Quintrio
Home

SERVICES-MANAGEMENT SERVICES

Evolent Health, Inc Class A Common Stock

EVH

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.

Last trade $4.66
Day change -$0.17 (-3.52%)
Day range $4.55 – $5.02
Volume 767,202
Market cap $546M

Open XNYS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$546.3M
Price / earnings
—
Price / book
1.47×
Price / sales
0.23×
EV / sales
0.58×
EV / EBITDA
21.71×

Profitability

Earnings per share
-$4.49
Return on assets
-25.87%
Return on equity
-136.17%
Dividend yield
0%

Liquidity and leverage

Debt / equity
2.6×
Current ratio
1.26×
Quick ratio
1.26×
Cash ratio
0.3×

Cash flow

Price / cash flow
8.42×
Price / free cash flow
9.56×
Free cash flow
$57.12M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for EVH, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$725.37M$652.52M$496.25M$468.72M$479.53M$444.33M$483.65M$646.54M
Cost of revenue$636.95M$571.68M$412.47M$371.47M$379.76M$343.94M$381.18M$570.83M
Gross profit$88.42M$80.84M$83.77M$97.25M$99.77M$100.39M$102.47M$75.71M
Selling, general and administrative$73.12M$68.83M$72.82M$72.66M$77.59M$75.21M$78.41M$47.7M
Research and development$0$0$0$0$0$0$0$0
Total operating expenses$94.61M$90.4M$94.37M$520.35M$100.12M$101.56M$102.47M$94.31M
Operating income-$6.19M-$9.56M-$10.6M-$423.1M-$344K-$1.17M$4K-$18.6M
Interest expense-$17M-$16.86M-$16.87M-$19.01M-$16.48M-$11.6M-$10.39M-$6.72M
Income before taxes-$22.45M-$25.65M-$25.72M-$430.81M-$19.96M-$20.72M-$63.15M-$23.92M
Income taxes$1.12M$2.72M$910K-$1.68M$906K-$825K$1.47M-$1.12M
Net income-$23.57M-$28.36M-$26.63M-$429.13M-$20.86M-$19.9M-$64.62M-$22.8M
Net income attributable to common shareholders-$23.57M-$28.36M-$26.63M-$429.13M-$26.93M-$51.09M-$72.25M-$30.62M
EBITDA$16.32M$13.1M$11.89M$21.71M$26.45M$23.26M$25.3M$33.4M
Basic earnings per share-$0.21-$0.25-$0.24-$3.85-$0.24-$0.44-$0.63-$0.27
Diluted earnings per share-$0.21-$0.25-$0.24-$3.85-$0.24-$0.44-$0.63-$0.27

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

American Well (AMWL) Surges 6.1%: Is This an Indication of Further Gains?

American Well (AMWL) shares jumped 6.1% to $14.98 on investor optimism ahead of Q3 2026 earnings expected November 3. The company is projected to report a quarterly loss of $0.66 per share (62.1% improvement year-over-year) with revenues of $47.06 million (down 16.4%). However, with unchanged earnings estimate revisions over the past 30 days, analysts caution that the stock may struggle to sustain momentum without positive estimate trends. AMWL carries a Zacks Rank #3 (Hold).

GlobeNewswire Inc.

Global Value-Based Healthcare Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight

The value-based healthcare market is experiencing robust growth, projected to reach USD 62 billion by 2034 from USD 16.5 billion in 2025, with a CAGR of ~16%. The shift from fee-for-service to outcome-based payment models is driven by rising healthcare costs, chronic disease burden, and government reimbursement reforms. North America dominates with 72% market share, while Asia-Pacific is expected to record the fastest growth. Key players include Optum, Humana, Evolent Health, Agilon Health, and Privia Health.

GlobeNewswire Inc.

Global Technology Spending On Core Administration in Healthcare Market Size To Worth USD 61.5 Billion By 2033 | CAGR Of 5.86%

The global technology spending on core administration in healthcare market is expected to grow from $34.8 billion in 2023 to $61.5 billion by 2033, at a CAGR of 5.86%. The growth is driven by advancements in technologies like edge computing, IoT, and cloud storage, as well as the need for operational efficiency and regulatory compliance.

Zacks Investment Research

Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.